The Brown Political Review examines the trends in healthcare data breaches since COVID-19 began. The discussion aims to understand the question of data ownership amid the increasing incidences of cybercriminal activities exploiting the vulnerabilities in the healthcare sector caused by pandemic-induced changes.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
